A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer

Figure 3

Risk scores, risk curves, and 8-gene signature heatmaps of PAAD patients in all cohorts. The distribution trend of risk score, OS time, PFS time, and DSS time in the training group (a), validation group (b), and entire cohort (c). Expression levels of 8-gene signature in the high-risk and low-risk groups in the training group (d), validation group (e), and entire cohort (f). OS: overall survival; PFS: progression-free survival; DSS: disease-specific survival.